Scientists at NIH’s Rocky Mountain Lab inoculated 6 monkeys with single doses of Oxford vaccine. The monkeys were then exposed to heavy quantities of the virus — exposure that had sickened other monkeys. But more than 28 days later all six were healthy
The race for a vaccine: Scientists inoculated six rhesus macaque monkeys with single doses of a vaccine. The animals were then exposed to heavy quantities of the virus that is causing the pandemic. More than 28 days later all six were healthy.
At last, some good news. Oxford vaccine is showing promise! 1. six rhesus macaques have gained immunity 2. university has already established method to make millions of doses 3. if successful, vaccine makers across the world will get non-exclusive licenses
Oxford scientists now say that with an emergency approval from regulators, the first few million doses of their vaccine could be available by September — at least several months ahead of any of the other announced efforts — if it proves to be effective
Scientists at Oxford University are sprinting ahead with trials for their coronavirus vaccine, which has now shown a promising result in monkeys
Some hopeful news! Scientists at Oxford University report that their vaccine work is going well –– six monkeys given the vaccine are all healthy 28 days after being exposed to the virus (not the case for monkeys who got no vaccine)
"The Oxford scientists now say that with an emergency approval from regulators, the first few million doses of their vaccine could be available by September—at least several months ahead of any of the other announced efforts—if it proves to be effective."
Prof. behind Oxford vaccine in development: "I personally don’t believe that in a time of pandemic there should be exclusive licenses”
Extremely promising news but note: "Ethics rules, as a general principal, forbid seeking to infect human test participants with a serious disease.” Change the rules!
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
you want some promising news, here’s some promising news
This is wonderful news. And a badly needed cause for a bit of optimism — the Oxford vaccine worked on monkeys and thousands of people will be vaccinated to test for efficacy & safety with the hopes of it being ready in September.
Sept vaccine? “Oxford scientists now say that with an emergency approval from regulators, the first few million doses of their vaccine could be available by September — if it proves to be effective.” #COVID19
The Oxford scientists now say that with an emergency approval from regulators, the first few million doses of their vaccine could be available by September
This is the single most promising thing I’ve seen about #COVID19.
Are you starting to believe me now or what?
sounds too good to be true. But who knows. via
We're going to be the last country in the world with widespread access to a vaccine, aren't we
It would be depressing, though perhaps not surprising, if a desire for super-profits and exclusive licensing meant that the United States got a successful vaccine more slowly than Europe.
In the worldwide race for a vaccine to stop the coronavirus, the laboratory sprinting fastest is at Oxford University
UK funding is driving the search for a cure at ⬇️
Manufacturers around the world ramp up production of a promising new vaccine. But not in North America, where big pharma companies demand exclusivity. Advocates of IP solutions to public health problems need to take a long hard look at this.
Promising #COVID19 vaccine trial results in monkeys from - Now scheduling tests of new #vaccine involving more than 6,000 people by the end of next month
The women's studies department at Oxford must be very triggered right now.
British university leading the race for a vaccine. Meanwhile,the government sits idly by as British universities sink into the financial abyss.
“The Oxford scientists say that with an emergency approval from regulators, the first few million doses of their vaccine could be available by September — at least several months ahead of any of the other announced efforts — if it proves to be effective.“
It's always seemed to me like a vaccine being available ahead of schedule—or even at all—was less likely than people keep saying. But I'd be extremely happy to be wrong
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
Tolkien said it was "cellar door," but I contend the most beautiful phrase in the English language is "could be available by September."
Fingers crossed for ⁦⁩ COVID-19 vaccine candidate via ⁦
“It did not stay a ‘little lab project’ for very long.” So proud to see this in ⁦⁩ - testament to whole team effort by many! Lucky to have my PhD supervised by Adrian. #COVID19 #SARS_CoV2 #VaccinesWork
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
“But the team has not yet reached an agreement with a North American manufacturer, in part because the major pharmaceutical companies there typically demand exclusive worldwide rights before investing in a potential medicine.” #MedTwitter ⁦
🤞🤞🤞 “In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead”
A very good overview of the efforts here at the University to develop the vaccine against COVID-19. It has proven successful in a trial with monkeys and the hope is that in a best case scenario ‘the first few million doses could be available by September’
This seems like legitimately good news.
4/ First: Will we have a vaccine, the only true gamechanger. Hopeful signs : . Remember: need to invent, be sure it works & is safe, make 300M doses, & inject into 300M arms (just in US!). No realistic hope this’ll happens in '20; ‘21 maybe
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
Good read on #covid19 vaccine dev. Addresses #IP issues: “I personally don’t believe that in a time of pandemic there should be exclusive licenses,” Prof Hill said “So we are asking a lot of them. Nobody is going to make a lot of money off this.”⁩
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
Funding science before you need it pays off. There is no substitute for a robust system of basic science to help us when a crisis hits, especially when we cannot predict which tools we will need.
1. This article spotlights potentially excellent news, but also points to why we should use human-challenge trials to test coronavirus vaccines - Phase III trials take too long and may not even be able to prove whether a vaccine works one way or the other.
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
Why not a US firm? "The (Oxford) team has not yet reached an agreement with a North American manufacturer, in part because the major pharmaceutical companies there typically demand exclusive worldwide rights before investing in a potential medicine."
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
Could Oxford be first?
Rhesus macaque monkeys at a US NIH lab inoculated last month with the Oxford Jenner Institute Covid-19 vaccine, and exposed to the virus, have remained healthy
"Immunity in monkeys is no guarantee that a vaccine will provide the same degree of protection for humans...[but] the monkey results are the latest indication that Oxford’s accelerated venture is emerging as a bellwether."
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead - The New York Times
In Race for a #Coronavirus Vaccine, an Group Leaps Ahead.
Vaccine group from will enroll 6000 patients by end of May.
*** Great news for the day regarding #COVID19! *** In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
The COVID-19 vaccine candidate racing ahead: Oxford's "last week began a Phase I clinical trial involving 1,100 people. Crucially, next month it will begin a combined Phase II and Phase III trial involving another 5,000."
“The Oxford scientists now say that with an emergency approval from regulators, the first few million doses of their vaccine could be available by September ”
Good news from Oxford today: perhaps we’ll have a Covid-19 vaccine by the end of the year after all!
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
“I personally don’t believe that in a time of pandemic there should be exclusive licenses,” Professor Hill said. “So we are asking a lot of them. Nobody is going to make a lot of money off this.”
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
It's early days yet but initial results from the Oxford vaccine look promising
Promising progress by Oxford—hoping its COVID-19 vaccine will be available at mass scale before next flu season
Time for some hope !
Maybe some good news about a vaccine? via
Nice focus on the work of Adrian Hill and Sarah Gilbert In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
A glimmer of good news - via
In race for a #Coronavirus #Vaccine, an Oxford group with its recombinant adenoviral vector vaccine with leaps ahead. #COVID19
Encouraging news...
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead - The New York Times
. reports on Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
In Race for a #Coronavirus #Vaccine, an #Oxford University Group Leaps Ahead
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
"Ethics rules, as a general principal, forbid seeking to infect human test participants with a serious disease" Load of tosh. The flu is more dangerous to 20-30 year olds. There should be some flex in the rules to account for objective severity metrics.
The Most Promising Evidence Yet of a Corona Vaccine that Might Actually Work!
A promising vaccine trial. The article brings up a fascinating ethical issue: they can't (deliberately) expose the trial participants to COVID, of course. So they must solicit volunteers that live in hotspots & wait to see if control group gets virus.
via . Cautious big picture optimism.
In Race for a #Coronavirus #Vaccine, an Oxford Group Leaps Ahead
"But demonstrating the effectiveness of a vaccine in China may be difficult because Covid-19 infections there have plummeted."
I had been looking for updates on the Oxford vaccine
The New York Times: In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead. via
Vaccine in September? Hmm
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead